Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

TPE in Heparin-Induced Thrombocytopenia (HIT) - Clinical Trial

What is the Purpose of this Study?

We are doing this study is to understand how TPE (therapeutic plasma exchange) can help to decrease blood-clotting risk in patients.
What is the Condition Being Studied?
Heparin-induced thrombocytopenia (HIT)

Who Can Participate in the Study?

Adult men and women who are:
- Receiving unfractionated heparin (UFH) or low molecular weight heparin (LMWH).

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Participate in the study for about 30 days
- Provide blood samples throughout the study

Study Details

Full Title
Defining the Role of Therapeutic Plasma Exchange in Heparin Induced Thrombocytopenia
Principal Investigator
Protocol Number
IRB: PRO00086436
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698